Pentair, Inc. (NYSE: PNR), ViroPharma Incorporated (NASDAQ: VPHM), Pharmacyclics, Inc. (NASDAQ: PCYC), Broadcom Corp. (NASDAQ: BRCM), Charles River Laboratories (NYSE: CRL) and EnCana Co. (NYSE: ECA) had price targets on them adjusted by analysts.
Pentair, Inc. (PNR) had its price target raised by Wedbush to $47.00.
ViroPharma Incorporated (VPHM) had its price target raised by Bank of America (NYSE:BAC) to $32.00. They have a “Buy” rating on the company.
Pharmacyclics, Inc. (PCYC) had its price target raised by Rodman & Renshaw to $22.00.
Broadcom Corp. (BRCM) had its price target lowered by Auriga to $35.00.
Charles River Laboratories (CRL) had its price target lowered by Citigroup (NYSE:C) to $31.00. They have a “Neutral” rating on the company.
EnCana Co. (ECA) had its price target lowered by Credit Suisse (NYSE:CS) to $27.00. They have an “Outperform” rating on the company.
No comments:
Post a Comment